Miquel Oliu-Barton
Miquel Oliu-Barton is a non-resident fellow at Bruegel. He is also an associate professor of economics at Paris-Dauphine University.
Game theorist by training, Miquel has led numerous policy and scientific publications (Lancet, Lancet Global Health, Nature Communications, BMJ) that were cited in leading international media including CNN, Financial Times, New York Times and Le Monde. His work builds on multidisciplinary collaborations between scientists and policy-makers from different countries. At Bruegel, he is part of Europe’s governance team.
Miquel graduated from the Ecole normale supérieure in mathematics, holds a Ph.D. from Sorbonne University, and was recently a visiting Professor at Yale University. He is fluent in English, French, Spanish and Italian.
Disclosure of interests
Featured work
How much does Europe pay for clean air?
Despite major progress, the cost of air pollution is still huge for the European Union
Addressing air pollution in the EU: financing and policy
This event centered on funding for clean air in the EU and key challenges facing clean air policies.
EU air quality agreement sends a positive signal but leaves loopholes
EU air quality agreement sends a positive signal but leaves loopholes
Implementation of tighter EU air quality standards will need careful monitoring in case of circumvention
Funding clean air in Europe: best practices and hurdles
This online-only workshop examines EU funding for air quality improvements and aims to identify best practices.
How close is Europe to winning the fight against air pollution?
A multinational Delphi consensus to end the COVID-19 public health threat
Climate club ‘green certificate’ would boost membership
An individual tax on fuel consumption is an effective, flexible and sustainable solution to combat inflation
The effect of COVID certificates on vaccine uptake, public health, and the economy
An analysis of the incentive effects of COVID certificates on vaccine uptake, health outcomes and the economy.
Europe must come together to confront Omicron
Statement published in the renowned British Medical Journal (BMJ) to address the wave of the Omicron variant of SARS-CoV-2.
Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines
Article published in Lancet Global Heath on strategies to end the COVID-19 pandemic in the presence of effective vaccines.
Aiming for zero COVID-19: Europe needs to take action
Aiming for 'green zones' offers a clear path to navigate an exit from the pandemic with as little damage as possible. Europe should not miss the oppor